QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Lumos Pharma (LUMO) SEC Filings & 10K Form

$2.94
-0.08 (-2.65%)
(As of 02/23/2024 ET)

Recent Lumos Pharma SEC Filings

DateFilerForm TypeView
02/09/2024
6:14 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13G/A
02/07/2024
4:22 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McKew John C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
8:57 AM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
WELLS FARGO & COMPANY/MN (Filed by)
Form SC 13G
02/05/2024
4:51 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
POWERS BRADLEY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:52 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Schuchart Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:53 PM
Lawley Lori D (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
6:03 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Pitukcheewanont Pisit Duke (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2023
3:30 PM
Blackstone Holdings II L.P. (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13D/A
11/15/2023
3:38 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
4:00 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
3:42 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:34 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
8:32 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
2:54 PM
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
McKew John C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2023
3:26 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:10 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
5:05 AM
Farb Daniel Stuart (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13D/A
06/02/2023
10:14 AM
Farb Daniel Stuart (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13D/A
05/25/2023
11:10 AM
Farb Daniel Stuart (Filed by)
LUMOS PHARMA, INC. (Subject)
Lumos Pharma (Subject)
Form SC 13D/A
05/12/2023
4:43 PM
JOHNSON CHAD ALLEN (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
4:44 PM
LALANDE KEVIN M. (Reporting)
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
4:44 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
McCracken Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
4:44 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
4:45 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
van Es-Johansson An (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
4:45 PM
LUMOS PHARMA, INC. (Issuer)
Lumos Pharma (Issuer)
Zoth Lota S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
8:29 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/07/2023
5:02 AM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2023
3:51 PM
LUMOS PHARMA, INC. (Filer)
Lumos Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LUMO) was last updated on 2/23/2024 by MarketBeat.com Staff